http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101304980-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-04
filingDate 2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d0d17d53c30ea2353397c3dc8cee288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d5f8a0f575200d5350f4330a2a2f81d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_667463ae2bc758de4aac336cddf99925
publicationDate 2011-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101304980-B
titleOfInvention 3-(4-piperidinyl)-2,3,4,5,-tetrahydro-1, 3-benzodiaza-2 (1H)-one
abstract The invention relates to a method for producing the compound 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepine-2(1H)-one of formula (I), which can be found as a structural element in CGRP antagonists that are suited especially for the oral treatment of migraine.
priorityDate 2005-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3474090-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6204262-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11379587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419820473

Total number of triples: 21.